Caitlyn Norman

Publications

2026

Giorgia Corli, Deborah Rudin, Dino Luethi, Matthias E. Liechti, Sabrine Bilel, Matteo Marti, Henrik Green, Manuela Monti, Caitlyn Norman (2026) 5-HT2A receptor agonism by tert-leucinamide and valinamide synthetic cannabinoids: In vitro and in vivo evidence British Journal of Pharmacology (Article in journal) https://dx.doi.org/10.1111/bph.70457

Blake Curtis, Douglas J. Lawes, Mattias Persson, David Caldicott, Henrik Green, Caitlyn Norman, Malcolm D. McLeod (2026) Identification of isotocyanozene at an Australian drug checking service FORENSIC CHEMISTRY, Vol. 49, Article 100744 (Article in journal) https://dx.doi.org/10.1016/j.forc.2026.100744

Caitlyn Norman, Sara Liin, Amaia Jauregi Miguel, Nina Ottosson, Henrik Green (2026) In vitro γ-aminobutyric acid A (GABA_A) receptor activity and binding interactions at the α⁺/γ₂^- interface of 53 prescription and designer benzodiazepines Communications Chemistry, Vol. 9, Article 155 (Article in journal) https://dx.doi.org/10.1038/s42004-026-02001-x

2025

Manuela Monti, Tobias Rautio, Marie H. Deventer, Markus Schlapfer, Johannes Tveit, Alex J. Krotulski, Victoria Marland, Robert Reid, Niamh Nic Daeid, Craig McKenzie, Christophe P. Stove, Henrik Green, Caitlyn Norman (2025) Tail-less precursors in synthetic cannabinoid production: investigating a clandestine laboratory, seized samples, and CB1 activity Archives of Toxicology, Vol. 99, p. 3641-3661 (Article in journal) https://dx.doi.org/10.1007/s00204-025-04086-0

Henrik Green, Craig McKenzie, Elias Hamra, Tobias Rautio, Xiongyu Wu, Emma Juneskog, Rebecka Sandblom, Manuela Monti, Mattias Persson, Caitlyn Norman (2025) In vitro CB1 receptor activity of halogenated indazole synthetic cannabinoid receptor agonists Archives of Toxicology, Vol. 99, p. 3343-3353 (Article in journal) https://dx.doi.org/10.1007/s00204-025-04082-4